Apogee Therapeutics APGE Insider Ownership

NASDAQ APGE
$135.07 -0.01 (-0.01%)
At close: Sep 2, 2026 · 4:00 PM EDT

Insider Holdings by Owner

3.03Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.303%
Shares Held by Insiders
177.87K
filed for Sep 2026
Shares Outstanding
58.77Mn
58,773,731 shares
Direct Holdings
177.87K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of APGE are Nimish P Shah (Director, 1.75Mn shares), Nimish P Shah (Director, 1.75Mn shares), Michael Thomas Henderson (Chief Executive Officer, 920.94K shares).

Form 4 Holdings

Insiders Holding APGE

Insiders 5
Shares held 3.03Mn
Of outstanding 5.15%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Nimish P Shah Director 0 1,750,000 1,750,000 57.8% 17 Jul, 2023
2 Michael Thomas Henderson Chief Executive Officer 920,941 0 920,941 30.4% 10 Jul, 2026
3 Carl Dambkowski Chief Medical Officer 177,873 0 177,873 5.9% 02 Jul, 2026
4 Jane Henderson Chief Financial Officer 158,371 0 158,371 5.2% 24 Jul, 2026
5 Mark C. Mckenna Director 20,000 0 20,000 0.7% 16 Dec, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

143 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
24 Jul, 2026 Jane Henderson Chief Financial Officer Disposed G 15,000 $0.00 $0 158,371 Direct
08 Jul, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 20,000 $133.63 $2.67Mn 995,987 Direct
10 Jul, 2026 Michael Thomas Henderson Chief Executive Officer Disposed G 75,046 $0.00 $0 920,941 Direct
01 Jul, 2026 Carl Dambkowski Chief Medical Officer Acquired M 4,125 $22.86 $94.30K 183,373 Direct
01 Jul, 2026 Carl Dambkowski Chief Medical Officer Disposed S 5,500 $132.74 $730.07K 177,873 Direct
01 Jul, 2026 Carl Dambkowski Chief Medical Officer Disposed M 4,125 $0.00 $0 114,790 Direct
22 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 80,000 $132.54 $10.60Mn 1,015,987 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 6,770 $82.21 $556.56K 1,109,217 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 7,654 $82.78 $633.60K 1,101,563 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 1,080 $84.18 $90.91K 1,100,483 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 1,577 $85.19 $134.34K 1,098,906 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 2,305 $86.27 $198.85K 1,096,601 Direct
10 Jun, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 614 $86.89 $53.35K 1,095,987 Direct
09 Jun, 2026 Nimish P Shah Director Acquired A 7,657 $0.00 $0 7,657 Direct
09 Jun, 2026 Jennifer A. Fox Director Acquired A 7,657 $0.00 $0 7,657 Direct
09 Jun, 2026 William A Jr Jones Director Acquired A 7,657 $0.00 $0 7,657 Direct
09 Jun, 2026 Mark C. Mckenna Director Acquired A 7,657 $0.00 $0 7,657 Direct
09 Jun, 2026 Lisa Bollinger Director Acquired A 7,657 $0.00 $0 7,657 Direct
13 May, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 18,659 $82.05 $1.53Mn 1,117,328 Direct
13 May, 2026 Michael Thomas Henderson Chief Executive Officer Disposed S 1,341 $82.58 $110.74K 1,115,987 Direct